Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities
Zita‐Rose Manjaly Thomas, Anne Leuppi-Taegtmeyer, Dagmar Jamiolkowski, Esther Helen Steveling, Felicitas Bellutti Enders, Kathrin Scherer Hofmeier, Karin Hartmann
Topics & Concepts
Coronavirus disease 2019 (COVID-19)DrugDrug reaction2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePharmacologyVirologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseDrug-Induced Adverse ReactionsDermatological and COVID-19 studiesCOVID-19 Clinical Research Studies